Take it at the wrong time and you're still getting benefits, but you're leaving some on the table
Is tirzepatide or semaglutide better
When medication changes your patterns, your brain might still crave food in the amounts and at the times it's used to
A related and widely referenced pairing combines a longer-acting GHRH analog, CJC-1295, with ipamorelin
Two-year sustained weight loss and metabolic benefits with controlled release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study
In a call with investors after the results were announced, Martin Lange, executive vice president of R&D, chief scientific officer and member of the Management Board for Novo Nordisk, explained that Zepbound performed unusually well on efficacy compared to what has typically been reported in most previous trials of a similar nature. In a phase 3 trial in adults with pre-diabetes and obesity, participants had an average weight reduction of 22.9% on the highest dose of tirzepatide, 2.1% less weight loss than was seen in the CagriSema comparator trial